Greetings, everyone. How are you this morning? We trust you feel invigorated as another day gets under way. As usual, we are brewing a delicious cup of stimulation and poking around for interesting items. Heard something fascinating? Send us a note. Meanwhile, we hope your workload is manageable and much gets accomplished. Catch you soon...
Pfizer Faces 1,200 Chantix Lawsuits (Birmingham News)
Spectrum To Make Biosimilar Of Roche's Rituximab (Reuters)
Roche Wins Wider Approval For Actemra (Bloomberg News)
Evidence Links Avastin To Heart Failure In Breast Cancer Patients (HealthDay)
EMA Worries Over Foreign APIs (InPharma-Technologist)
J&J Files For FDA Approval Of Bloodthinner (Associated Press)
Celgene Submits New Applications For Cancer Meds (Reuters)
Xoma Inks $505M Diabetes Drug Deal With Servier (San Francisco Business Times)
Bayers Seeks EU Approval For Xarelto (Reuters)
Physician Use Of Mobile Phone Apps Is Rising (PharmaTimes)
Several Accutane Lawsuits Scheduled For Trial In 2011 (DrugWatch)